Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.36
GB's Cash to Debt is ranked lower than
79% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 2.56 vs. GB: 0.36 )
Ranked among companies with meaningful Cash to Debt only.
GB' s 10-Year Cash to Debt Range
Min: 0.01  Med: 0.20 Max: N/A
Current: 0.36
Equity to Asset 0.66
GB's Equity to Asset is ranked higher than
51% of the 282 Companies
in the Global Medical Devices industry.

( Industry Median: 0.66 vs. GB: 0.66 )
Ranked among companies with meaningful Equity to Asset only.
GB' s 10-Year Equity to Asset Range
Min: 0.28  Med: 0.54 Max: 0.75
Current: 0.66
0.28
0.75
Interest Coverage 17.79
GB's Interest Coverage is ranked lower than
77% of the 166 Companies
in the Global Medical Devices industry.

( Industry Median: 10000.00 vs. GB: 17.79 )
Ranked among companies with meaningful Interest Coverage only.
GB' s 10-Year Interest Coverage Range
Min: 0.05  Med: 3.70 Max: 17.79
Current: 17.79
0.05
17.79
F-Score: 6
Z-Score: 4.23
M-Score: -2.74
WACC vs ROIC
12.73%
6.46%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 9.26
GB's Operating margin (%) is ranked higher than
70% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 3.12 vs. GB: 9.26 )
Ranked among companies with meaningful Operating margin (%) only.
GB' s 10-Year Operating margin (%) Range
Min: 0.2  Med: 10.93 Max: 17.66
Current: 9.26
0.2
17.66
Net-margin (%) 7.19
GB's Net-margin (%) is ranked higher than
70% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 1.99 vs. GB: 7.19 )
Ranked among companies with meaningful Net-margin (%) only.
GB' s 10-Year Net-margin (%) Range
Min: -2.87  Med: 5.64 Max: 10.76
Current: 7.19
-2.87
10.76
ROE (%) 8.12
GB's ROE (%) is ranked higher than
62% of the 287 Companies
in the Global Medical Devices industry.

( Industry Median: 3.14 vs. GB: 8.12 )
Ranked among companies with meaningful ROE (%) only.
GB' s 10-Year ROE (%) Range
Min: -2.39  Med: 5.68 Max: 10.53
Current: 8.12
-2.39
10.53
ROA (%) 5.24
GB's ROA (%) is ranked higher than
67% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: -0.33 vs. GB: 5.24 )
Ranked among companies with meaningful ROA (%) only.
GB' s 10-Year ROA (%) Range
Min: -1.07  Med: 3.56 Max: 6.21
Current: 5.24
-1.07
6.21
ROC (Joel Greenblatt) (%) 21.03
GB's ROC (Joel Greenblatt) (%) is ranked higher than
71% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 3.55 vs. GB: 21.03 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
GB' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 0.69  Med: 23.55 Max: 47.6
Current: 21.03
0.69
47.6
Revenue Growth (3Y)(%) 3.20
GB's Revenue Growth (3Y)(%) is ranked higher than
53% of the 194 Companies
in the Global Medical Devices industry.

( Industry Median: 2.90 vs. GB: 3.20 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
GB' s 10-Year Revenue Growth (3Y)(%) Range
Min: 0.2  Med: 11.00 Max: 30.3
Current: 3.2
0.2
30.3
EBITDA Growth (3Y)(%) 1.90
GB's EBITDA Growth (3Y)(%) is ranked lower than
51% of the 173 Companies
in the Global Medical Devices industry.

( Industry Median: 2.10 vs. GB: 1.90 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
GB' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -7.6  Med: 5.90 Max: 30.6
Current: 1.9
-7.6
30.6
EPS Growth (3Y)(%) 15.20
GB's EPS Growth (3Y)(%) is ranked higher than
69% of the 173 Companies
in the Global Medical Devices industry.

( Industry Median: -0.40 vs. GB: 15.20 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
GB' s 10-Year EPS Growth (3Y)(%) Range
Min: -20  Med: 8.90 Max: 146.6
Current: 15.2
-20
146.6
» GB's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

GB Guru Trades in Q2 2014

Joel Greenblatt 250,635 sh (+80.33%)
Chuck Royce 107,000 sh (+52.86%)
Jim Simons 161,300 sh (+43.65%)
Mario Gabelli 227,100 sh (-6.77%)
Diamond Hill Capital 414,221 sh (-17.94%)
» More
Q3 2014

GB Guru Trades in Q3 2014

Ken Fisher 609,572 sh (New)
Paul Tudor Jones 18,514 sh (New)
Joel Greenblatt 264,417 sh (+5.50%)
Diamond Hill Capital 411,516 sh (-0.65%)
Mario Gabelli 194,100 sh (-14.53%)
Jim Simons 107,100 sh (-33.60%)
Chuck Royce 60,408 sh (-43.54%)
» More
Q4 2014

GB Guru Trades in Q4 2014

Joel Greenblatt 296,657 sh (+12.19%)
Ken Fisher 616,332 sh (+1.11%)
Diamond Hill Capital 412,640 sh (+0.27%)
Mario Gabelli 173,600 sh (-10.56%)
Chuck Royce 42,501 sh (-29.64%)
Paul Tudor Jones 9,328 sh (-49.62%)
Jim Simons 53,900 sh (-49.67%)
» More
Q1 2015

GB Guru Trades in Q1 2015

Paul Tudor Jones Sold Out
Jim Simons Sold Out
Ken Fisher 612,832 sh (-0.57%)
Diamond Hill Capital 389,540 sh (-5.60%)
Mario Gabelli 163,000 sh (-6.11%)
Joel Greenblatt 241,538 sh (-18.58%)
Chuck Royce 34,001 sh (-20.00%)
» More
» Details

Insider Trades

Latest Guru Trades with GB

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 28.39
GB's P/E(ttm) is ranked lower than
53% of the 156 Companies
in the Global Medical Devices industry.

( Industry Median: 27.60 vs. GB: 28.39 )
Ranked among companies with meaningful P/E(ttm) only.
GB' s 10-Year P/E(ttm) Range
Min: 11.04  Med: 30.36 Max: 575.08
Current: 28.39
11.04
575.08
Forward P/E 18.08
GB's Forward P/E is ranked higher than
61% of the 96 Companies
in the Global Medical Devices industry.

( Industry Median: 22.17 vs. GB: 18.08 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 28.60
GB's PE(NRI) is ranked lower than
52% of the 154 Companies
in the Global Medical Devices industry.

( Industry Median: 27.80 vs. GB: 28.60 )
Ranked among companies with meaningful PE(NRI) only.
GB' s 10-Year PE(NRI) Range
Min: 11.04  Med: 30.86 Max: 534
Current: 28.6
11.04
534
P/B 2.13
GB's P/B is ranked higher than
64% of the 288 Companies
in the Global Medical Devices industry.

( Industry Median: 3.13 vs. GB: 2.13 )
Ranked among companies with meaningful P/B only.
GB' s 10-Year P/B Range
Min: 0.97  Med: 1.51 Max: 2.46
Current: 2.13
0.97
2.46
P/S 2.05
GB's P/S is ranked higher than
61% of the 291 Companies
in the Global Medical Devices industry.

( Industry Median: 3.19 vs. GB: 2.05 )
Ranked among companies with meaningful P/S only.
GB' s 10-Year P/S Range
Min: 0.78  Med: 1.32 Max: 2.97
Current: 2.05
0.78
2.97
PFCF 29.18
GB's PFCF is ranked higher than
53% of the 116 Companies
in the Global Medical Devices industry.

( Industry Median: 31.45 vs. GB: 29.18 )
Ranked among companies with meaningful PFCF only.
GB' s 10-Year PFCF Range
Min: 6.12  Med: 26.02 Max: 169.91
Current: 29.18
6.12
169.91
POCF 16.96
GB's POCF is ranked higher than
63% of the 149 Companies
in the Global Medical Devices industry.

( Industry Median: 21.48 vs. GB: 16.96 )
Ranked among companies with meaningful POCF only.
GB' s 10-Year POCF Range
Min: 5.14  Med: 11.00 Max: 26.7
Current: 16.96
5.14
26.7
EV-to-EBIT 21.61
GB's EV-to-EBIT is ranked higher than
52% of the 163 Companies
in the Global Medical Devices industry.

( Industry Median: 22.11 vs. GB: 21.61 )
Ranked among companies with meaningful EV-to-EBIT only.
GB' s 10-Year EV-to-EBIT Range
Min: 8.3  Med: 24.50 Max: 3207.3
Current: 21.61
8.3
3207.3
PEG 3.18
GB's PEG is ranked higher than
51% of the 55 Companies
in the Global Medical Devices industry.

( Industry Median: 3.18 vs. GB: 3.18 )
Ranked among companies with meaningful PEG only.
GB' s 10-Year PEG Range
Min: 0.71  Med: 5.22 Max: 920.69
Current: 3.18
0.71
920.69
Shiller P/E 53.68
GB's Shiller P/E is ranked lower than
72% of the 94 Companies
in the Global Medical Devices industry.

( Industry Median: 30.32 vs. GB: 53.68 )
Ranked among companies with meaningful Shiller P/E only.
GB' s 10-Year Shiller P/E Range
Min: 22.65  Med: 38.94 Max: 61.71
Current: 53.68
22.65
61.71
Current Ratio 3.85
GB's Current Ratio is ranked higher than
65% of the 311 Companies
in the Global Medical Devices industry.

( Industry Median: 2.69 vs. GB: 3.85 )
Ranked among companies with meaningful Current Ratio only.
GB' s 10-Year Current Ratio Range
Min: 1.6  Med: 3.23 Max: 8.42
Current: 3.85
1.6
8.42
Quick Ratio 2.27
GB's Quick Ratio is ranked higher than
53% of the 311 Companies
in the Global Medical Devices industry.

( Industry Median: 2.03 vs. GB: 2.27 )
Ranked among companies with meaningful Quick Ratio only.
GB' s 10-Year Quick Ratio Range
Min: 0.79  Med: 1.88 Max: 6.93
Current: 2.27
0.79
6.93
Days Inventory 103.27
GB's Days Inventory is ranked higher than
66% of the 281 Companies
in the Global Medical Devices industry.

( Industry Median: 131.50 vs. GB: 103.27 )
Ranked among companies with meaningful Days Inventory only.
GB' s 10-Year Days Inventory Range
Min: 86  Med: 99.29 Max: 121.04
Current: 103.27
86
121.04
Days Sales Outstanding 59.73
GB's Days Sales Outstanding is ranked higher than
63% of the 272 Companies
in the Global Medical Devices industry.

( Industry Median: 68.21 vs. GB: 59.73 )
Ranked among companies with meaningful Days Sales Outstanding only.
GB' s 10-Year Days Sales Outstanding Range
Min: 40.02  Med: 49.65 Max: 68.3
Current: 59.73
40.02
68.3

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 74.82
GB's Price/Net Current Asset Value is ranked lower than
97% of the 200 Companies
in the Global Medical Devices industry.

( Industry Median: 6.82 vs. GB: 74.82 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
GB' s 10-Year Price/Net Current Asset Value Range
Min: 62.2  Med: 108.40 Max: 3610
Current: 74.82
62.2
3610
Price/Tangible Book 7.01
GB's Price/Tangible Book is ranked lower than
67% of the 262 Companies
in the Global Medical Devices industry.

( Industry Median: 4.53 vs. GB: 7.01 )
Ranked among companies with meaningful Price/Tangible Book only.
GB' s 10-Year Price/Tangible Book Range
Min: 5.43  Med: 12.34 Max: 74.81
Current: 7.01
5.43
74.81
Price/Projected FCF 1.43
GB's Price/Projected FCF is ranked higher than
71% of the 109 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. GB: 1.43 )
Ranked among companies with meaningful Price/Projected FCF only.
GB' s 10-Year Price/Projected FCF Range
Min: 0.52  Med: 0.93 Max: 1.66
Current: 1.43
0.52
1.66
Price/DCF (Earnings Based) 3.65
GB's Price/DCF (Earnings Based) is ranked lower than
100% of the 16 Companies
in the Global Medical Devices industry.

( Industry Median: 1.63 vs. GB: 3.65 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.56
GB's Price/Median PS Value is ranked lower than
73% of the 261 Companies
in the Global Medical Devices industry.

( Industry Median: 1.13 vs. GB: 1.56 )
Ranked among companies with meaningful Price/Median PS Value only.
GB' s 10-Year Price/Median PS Value Range
Min: 0.61  Med: 1.41 Max: 4.02
Current: 1.56
0.61
4.02
Price/Graham Number 2.94
GB's Price/Graham Number is ranked lower than
60% of the 134 Companies
in the Global Medical Devices industry.

( Industry Median: 2.55 vs. GB: 2.94 )
Ranked among companies with meaningful Price/Graham Number only.
GB' s 10-Year Price/Graham Number Range
Min: 1.97  Med: 4.24 Max: 14.44
Current: 2.94
1.97
14.44
Earnings Yield (Greenblatt) (%) 4.62
GB's Earnings Yield (Greenblatt) (%) is ranked higher than
75% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 0.50 vs. GB: 4.62 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
GB' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 0.1  Med: 4.10 Max: 12
Current: 4.62
0.1
12
Forward Rate of Return (Yacktman) (%) 5.96
GB's Forward Rate of Return (Yacktman) (%) is ranked higher than
57% of the 99 Companies
in the Global Medical Devices industry.

( Industry Median: 4.13 vs. GB: 5.96 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
GB' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: 3.6  Med: 11.70 Max: 27
Current: 5.96
3.6
27

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:WGB.Germany,
Greatbatch Inc is a Delaware corporation was incorporated on July 11, 1997. The Company designs and manufactures critical components that help to advance medical device technology across various applications. The Company operates in two segments namely Greatbatch Medical and QiG Group. Greatbatch Medical designs and manufactures products where Greatbatch either owns the intellectual property or has unique manufacturing and assembly expertise. Its products include medical devices and components for the cardiac, neuromodulation, orthopaedics, portable medical, vascular and energy markets among others. The Greatbatch Medical segment also offers value-added assembly and design engineering services for medical devices that utilize its component products.. QiG segment develops medical device systems for some of healthcare's challenges and reflects Greatbatch's strategic evolution of its product offerings. Through the research and development professionals in QiG, the Company is now investing in three areas namely new medical device systems commercialization, collaborative programs with OEM customers, and strategic equity positions in start-up companies to grow a diversified and distinctive portfolio. The medical device systems developed by QiG are manufactured by Greatbatch Medical. The Company's customers include large multi-national original equipment manufacturers. The Company is subject to direct governmental regulation including the laws and regulations generally applicable to all businesses in the jurisdictions in which it operates.
» More Articles for GB

Headlines

Articles On GuruFocus.com
BlackBerry Seems To Be Making The Right Moves Mar 08 2014 
Diamond Hill Capital Buys EOG, BR, GB, TEVA, BGS, IWD, HCC Jan 20 2011 
Greatbatch Inc. Reports Operating Results (10-Q) Nov 09 2010 
Greatbatch Inc. Reports Operating Results (10-Q) Aug 10 2010 
Greatbatch Inc. Reports Operating Results (10-Q) May 12 2010 
Greatbatch Inc. Reports Operating Results (10-Q) Nov 10 2009 
Greatbatch Inc. Reports Operating Results (10-Q) Aug 11 2009 
Greatbatch, Inc. Reports Second Quarter 2009 Results Aug 04 2009 
Greatbatch Inc. Reports Operating Results (10-Q) May 12 2009 

More From Other Websites
Greatbatch, Inc. Elects Jean Hobby, M. Craig Maxwell and Filippo Passerini to Its Board of Directors Jul 07 2015
GREATBATCH, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements... Jul 07 2015
Greatbatch, Inc. Elects Jean Hobby, M. Craig Maxwell and Filippo Passerini to Its Board of Directors Jul 07 2015
Greatbatch, Inc. to Host Q2 2015 Earnings Conference Call Jun 30 2015
Greatbatch, Inc. to Host Q2 2015 Earnings Conference Call Jun 30 2015
Algostim, LLC to be Renamed Nuvectra Jun 05 2015
Algostim, LLC to be Renamed Nuvectra Jun 05 2015
GREATBATCH, INC. Financials May 19 2015
10-Q for Greatbatch, Inc. May 14 2015
GREATBATCH, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 14 2015
GREATBATCH, INC. Files SEC form 10-Q, Quarterly Report May 12 2015
Greatbatch (GB) Misses on Q1 Earnings, Sales; Shares Fall - Analyst Blog May 04 2015
Greatbatch, Inc. Announces the Appointment of Marcia A. Dall to Its Board of Directors May 01 2015
GREATBATCH, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements... May 01 2015
Greatbatch, Inc. Announces the Appointment of Marcia A. Dall to Its Board of Directors May 01 2015
Greatbatch misses Street 1Q forecasts Apr 30 2015
Greatbatch misses Street 1Q forecasts Apr 30 2015
Greatbatch Inc Earnings Call and to Discuss Spin-Off Its Algostim Subsidiary scheduled for 5:00 pm... Apr 30 2015
Greatbatch, Inc. Reports 2015 First Quarter Results Apr 30 2015
GREATBATCH, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Apr 30 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK